Prelude was founded in 2016 by tech entrepreneur Martín Varsavsky, Lee Equity Partners, and Reproductive Biology Associates. The company was established to educate and inform men and women about their fertility and provide access to the latest advances in reproductive science and technology through The Prelude Method. The Prelude Method is a four-step process that includes egg and sperm freezing, genetic testing, and single embryo transfer to preserve people’s ability to have healthy babies when they’re ready. By coupling earlier decision-making with advances in reproductive science and technology, The Prelude Method can deliver dramatically higher pregnancy success rates, potentially eliminating the need for infertility treatments later in life.